Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

302
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
04/28/2015 04/29/2015 04/30/2015 05/04/2015 05/05/2015 Date
134.4(c) 129(c) 129.9(c) 130.1(c) 126.45 Last
1 885 774 3 686 439 3 056 277 2 039 698 2 897 590 Volume
-2.86% -4.02% +0.70% +0.15% -2.81% Change
More quotes
Financials (€)
Sales 2015 46 779 M
EBIT 2015 7 514 M
Net income 2015 4 196 M
Debt 2015 18 763 M
Yield 2015 1,91%
Sales 2016 48 084 M
EBIT 2016 8 503 M
Net income 2016 5 193 M
Debt 2016 16 015 M
Yield 2016 2,13%
PER 2015 25,61
PER 2016 20,62
EV / Sales 2015 2,70x
EV / Sales 2016 2,57x
Capitalization 107 586 M
More Financials
Company
Bayer AG is engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
05/06 | 08:40amPresentation
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
07:06a BAYER : Boosting innovation capacities through venture capital and strategic col..
05:04a BAYER : Makrolon® Silent Sound for noise protection barriers -- Transparent nois..
04:04a BAYER : Achieving customized automotive interiors easily and cost-effectively --..
05/04DJISIS PHARMACEUTICALS : to License Anti-Clotting Drug to Bayer
05/04DJBAYER : Xarelto Gets China Approval for More Indications
04/30 MERCK : BRIEF: Bayer income slips due to Merck acquisition
04/30 Sanofi faces AGM row over cost of firing and hiring CEOs
04/30DJBayer Raises Sales Expectations Despite Fall in 1Q Profit -- Update
More news
Sector news : Pharmaceuticals - NEC
05:41pDJAbbVie Wraps Up Large Debt Sale for Pharmacyclics Deal
05:23pDJAbbVie Wraps Up Large Debt Sale For Pharmacyclics Deal
05:20p TSX in selloff mode as sentiment on U.S. economy sours
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2014The EUR 100 area as entry point
2014The EUR 104 resistance as main obstacle
More Strategies
News from SeekingAlpha
06:56a Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2015 Update
05/04 BLOOMBERG : Monsanto-Syngenta mega-merger would drive more deals
05/04 Isis Pharma inks $155M license deal with Bayer for ISIS-FXIrx
05/02 Bayer's (BAYRY) CEO Marijn Dekkers on Q1 2015 Results - Earnings Call Transcr..
04/30 BLOOMBERG : Monsanto approaches Syngenta again about a takeover


Comments 
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF